Home Products Antibodies Primary Antibodies AF4967SP

AF4967SP

Human Bcl9-2 Antibody, R&D Systems™

Manufacturer: R&D Systems

Select a Size

Pack Size	SKU	Availability	Price
Each of 1	AF4967SP-Each-of-1	In Stock	₹ 17,154.78

AF4967SP - Each of 1

₹ 17,154.78

In Stock

Quantity

Base Price: ₹ 17,154.78

GST (18%): ₹ 3,087.86

Total Price: ₹ 20,242.64

Antigen

BCL9-2

Classification

Polyclonal

Conjugate

Unconjugated

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Gene Alias

B-cell CLL/lymphoma 9-like, B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, Bcl92, BCL9-like protein, DLNB11, DLNB11BCL9-2, nuclear co-factor of beta-catenin signalling, Protein BCL9-2

Host Species

Sheep

Purification Method

Affinity Purified

Regulatory Status

RUO

Gene ID (Entrez)

283149

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Content And Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Applications

Western Blot

Concentration

LYOPH

Dilution

Western Blot 1 ug/mL

Gene Accession No.

Q86UU0

Gene Symbols

BCL9L

Immunogen

E. coli-derived recombinant human Bcl9-2 Met38-Val206 Accession # Q86UU0

Quantity

25 μg

Primary or Secondary

Primary

Test Specificity

Detects endogenous human Bcl9-2 in Western blots.

Target Species

Human

Isotype

IgG

Related Products

Description

BCL9-2 Polyclonal specifically detects BCL9-2 in Human samples
It is validated for Western Blot.

Compare Similar Items

Show Difference

R&D Systems

AF4967SP

Antigen:

BCL9-2

Classification:

Polyclonal

Conjugate:

Unconjugated

Formulation:

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Gene Alias:

B-cell CLL/lymphoma 9-like, B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, Bcl92, BCL9-like protein, DLNB11, DLNB11BCL9-2, nuclear co-factor of beta-catenin signalling, Protein BCL9-2

Host Species:

Sheep

Purification Method:

Affinity Purified

Regulatory Status:

RUO

Gene ID (Entrez):

283149

Reconstitution:

Reconstitute at 0.2 mg/mL in sterile PBS.

Content And Storage:

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Applications:

Western Blot

Concentration:

LYOPH

Dilution:

Western Blot 1 ug/mL

Gene Accession No.:

Q86UU0

Gene Symbols:

BCL9L

Immunogen:

E. coli-derived recombinant human Bcl9-2 Met38-Val206 Accession # Q86UU0

Quantity:

25 μg

Primary or Secondary:

Primary

Test Specificity:

Detects endogenous human Bcl9-2 in Western blots.

Target Species:

Human

Isotype:

IgG

R&D Systems

AF4968

Antigen:

CLEC14A

Classification:

Polyclonal

Conjugate:

Unconjugated

Formulation:

__

Gene Alias:

C14orf27, CEG1, chromosome 14 open reading frame 27, ClECT and EGF-like domain containing protein, C-type lectin domain family 14 member A, C-type lectin domain family 14, member A, EGF R5, EGFR5, EGFR-5, Epidermal growth factor receptor 5

Host Species:

Sheep

Purification Method:

Affinity Purified

Regulatory Status:

RUO

Gene ID (Entrez):

161198

Reconstitution:

Reconstitute at 0.2 mg/mL in sterile PBS.

Content And Storage:

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Applications:

Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF

Concentration:

LYOPH

Dilution:

Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, Immunocytochemistry 5-15 ug/mL, CyTOF-ready

Gene Accession No.:

Q86T13

Gene Symbols:

CLEC14A

Immunogen:

Mouse myeloma cell line NS0-derived recombinant human CLEC14A Glu22-Ala397 Accession # Q86T13

Quantity:

100 μg

Primary or Secondary:

Primary

Test Specificity:

Detects human CLEC14A in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant human (rh) CLEC1, rhCLEC2, rhCLEC3B, and rhCLEC10A is observed.

Target Species:

Human

Isotype:

IgG

A2B Chem

AF49682

Antigen:

Classification:

Conjugate:

Formulation:

Gene Alias:

Host Species:

Purification Method:

Regulatory Status:

Gene ID (Entrez):

Reconstitution:

Content And Storage:

Applications:

Concentration:

Dilution:

Gene Accession No.:

Gene Symbols:

Immunogen:

Quantity:

Primary or Secondary:

Test Specificity:

Target Species:

Isotype:

A2B Chem

AF49683

Antigen:

Classification:

Conjugate:

Formulation:

Gene Alias:

Host Species:

Purification Method:

Regulatory Status:

Gene ID (Entrez):

Reconstitution:

Content And Storage:

Applications:

Concentration:

Dilution:

Gene Accession No.:

Gene Symbols:

Immunogen:

Quantity:

Primary or Secondary:

Test Specificity:

Target Species:

Isotype:

Human Bcl9-2 Antibody, R&D Systems™

Select a Size

Select a Size

Properties

Antigen

Classification

Conjugate

Formulation

Gene Alias

Host Species

Purification Method

Regulatory Status

Gene ID (Entrez)

Reconstitution

Content And Storage

Applications

Concentration

Dilution

Gene Accession No.

Gene Symbols

Immunogen

Quantity

Primary or Secondary

Test Specificity

Target Species

Isotype

Related Products

R&D Systems

R&D Systems

R&D Systems

R&D Systems

R&D Systems

R&D Systems

R&D Systems

R&D Systems

Description

Compare Similar Items

Show Difference

R&D Systems

R&D Systems

A2B Chem

A2B Chem